Childhood Leukemia: Nancy Keene's Guide, and What NCI Says About Risk Groups Now

Childhood Leukemia: A Guide for Families, Friends and Caregivers was first published by O'Reilly in 1997. Nancy Keene wrote it after her own daughter was treated for leukemia, and she built it from extensive interviews with other parents, survivors and clinicians rather than from her family's experience alone. The book has gone through multiple later editions; the Internet Archive's catalog record for the third edition, published in 2002, lists it at 540 pages and notes it includes a detachable folded treatment record for families to use during care.

O'Reilly is better known as a publisher of technical and reference books, and that lineage shows in the book's structure: it is dense, thorough, and organized for lookup and reference rather than for a single continuous read. It reads less like a memoir and more like a comprehensive manual a family keeps at hand throughout a long treatment course.

The book covers childhood leukemia broadly, with acute lymphoblastic leukemia (ALL), the most common form in children, treated in the greatest depth, alongside acute myeloid leukemia (AML) and other, rarer types.

Because it has been revised across editions over nearly three decades, families should be attentive to which edition they are reading, since treatment specifics described in an earlier edition will not match current practice.

Keene has written similar family guides for other childhood cancers as well, and this book shares that series' underlying approach: extensive parent interviews combined with a clinician-reviewed account of the medical process, aimed at giving families both the practical detail and the sense that other families have navigated the same territory before them.

The book moves through the arc of a leukemia diagnosis and treatment in detail: what the diagnostic workup involves, how risk groups and treatment plans are determined, and then a phase-by-phase account of treatment, covering induction, consolidation and maintenance therapy, the same three-phase structure NCI describes for ALL treatment.

Substantial sections address the practical and logistical realities of a long pediatric cancer treatment course: managing side effects like nausea, hair loss, and increased infection risk, coordinating school during treatment, supporting siblings, and navigating the financial and insurance dimensions of extended care. Parent interviews are woven throughout, giving many chapters a first-person texture even though the book as a whole is reference-oriented rather than narrative.

There is a glossary of medical terminology, given how much specialized vocabulary a family encounters quickly after a leukemia diagnosis, and appendices oriented toward record-keeping, consistent with the detachable treatment record included in at least the edition cataloged here.

The book's core strength is comprehensiveness paired with lived experience. Because Keene interviewed a wide range of parents and clinicians rather than relying only on her own family's path, the book captures variation in how leukemia treatment actually unfolds for different children, rather than presenting one family's experience as representative.

Its account of treatment phases matches NCI's current structure closely: NCI describes childhood ALL treatment as proceeding through remission induction, aimed at killing leukemia cells in the blood and bone marrow; consolidation or intensification, aimed at remaining cells that could cause relapse; and maintenance, using lower doses to prevent recurrence. A book organized around this same three-phase structure gives families a framework that will still make sense when discussed with their own oncology team, even where specific drugs or doses have changed since any particular edition was printed.

The attention to siblings, school, and family logistics is also a genuine strength, since these practical dimensions of a long pediatric treatment course are often underserved in more narrowly clinical materials. A leukemia treatment course for a child can run for a long stretch once maintenance therapy is included, and few clinical resources address what that means for a family's daily routine, work schedules, and other children in the house over that span the way this book attempts to.

Because the book has existed since 1997 across several editions, the treatment specifics in any given printing reflect that edition's era, not necessarily current practice. Childhood ALL treatment has continued to be refined, including in areas like risk stratification and the use of specific chemotherapy combinations, so families should treat detailed treatment descriptions as a starting point for a conversation with their own oncology team rather than as current protocol.

The book's density, useful as a reference, can also be overwhelming for a family in the first days after diagnosis who needs orientation more than exhaustive detail. Some families report using it more as a reference to return to during specific phases of treatment than as something read cover to cover early on.

As with any book compiled substantially from parent interviews, the emotional and practical accounts reflect a range of individual experiences that will not all match a given family's own situation, particularly around prognosis and outcome, which vary by the child's specific risk group and response to treatment.

Many families encounter this book only after a diagnosis has already been made, but it is worth stating, separately from the book's content, what NCI and its childhood cancer materials list as reasons for parents to seek evaluation.

Warning signs associated with childhood leukemia can include persistent fatigue, unexplained bruising or bleeding, bone or joint pain, frequent infections, and pale skin, though NCI's broader symptom guidance for cancer overall applies here too: symptoms are usually caused by something other than cancer, and NCI's instruction remains to see a doctor for anything that does not improve after a few weeks, since cancer often causes no pain and pain is not the threshold to wait for. For a fuller list specific to childhood cancer, see childhood cancer warning signs for parents.

Since the book's original 1997 publication, treatment for childhood ALL has continued to be refined, including more precise risk stratification using genetic and molecular features of the leukemia, and adjustments to chemotherapy regimens based on accumulated trial results. NCI's current materials describe risk groups, standard, high, and very high, based on factors including age, white blood cell count at diagnosis, specific genetic changes, how quickly the leukemia responds to initial treatment, and the presence of Down syndrome, a more granular classification system than may appear in earlier editions of the book.

NCI is explicit that overall outcome depends on this combination of individual factors and does not offer a single survival percentage that applies broadly, noting that "responses to treatment can vary greatly." This caution matches the book's own general stance against treating any one family's experience as predictive of another's, even as specific treatment details in the book itself should be checked against current information from a child's own care team.

Long chemotherapy courses in children commonly affect appetite and eating, and the book addresses this among its side-effect content, though its detail on nutrition specifically is less extensive than its treatment and logistics sections.

NCI's general nutrition guidance for cancer treatment describes appetite loss, nausea, taste changes and mouth sores as common effects that can make it harder for a patient, adult or child, to get enough calories and protein during treatment, and recommends involving a registered dietitian when weight loss or persistent appetite loss becomes a concern. For a child specifically, growth and development add another dimension to nutrition during a long treatment course beyond what an adult guide would need to address, which is part of why an oncology team's own dietitian, rather than general guidance alone, matters for a child's specific plan.

It suits a family with a child newly diagnosed with leukemia who wants a comprehensive, reference-style guide covering the full arc of treatment and its practical demands, particularly one that values the perspective of other parents who have been through it. It works well as a book to return to at different phases of a long treatment course rather than one to finish in the early days, and many families report doing exactly that, keeping it nearby through induction and pulling it out again as maintenance therapy begins.

It suits less well a family looking for a short, immediate orientation to a diagnosis received hours or days ago, given its length and density, or anyone seeking guaranteed-current treatment protocols without cross-checking against their child's actual care team. For an overview matched to current information, see childhood leukemia and acute lymphoblastic leukemia (ALL).

Cancer Explained is free and ad-free, and you can support this work if it helped.

• Childhood Leukemia: A Guide for Families, Friends and Caregivers — Internet Archive catalog record
• NCI — Childhood Acute Lymphoblastic Leukemia Treatment (PDQ)
• NCI — Symptoms of Cancer
• NCI — Nutrition in Cancer Care (PDQ)

This page discusses Childhood Leukemia: A Guide for Families, Friends and Caregivers for education. It is not medical advice, and nothing here is a judgement of anyone's real medical care.